The American College of Cardiology (ACC) is recommending that clinicians use weight management medications as first-line treatment for obese patients to reduce cardiovascular disease risks (CVD). Its new guideline prioritizes pharmacologic weight management strategies for heart health, supporting the idea that multidisciplinary approaches can help improve therapies.
